文献速递肝胆胰外科

肝内胆管癌转移淋巴结数目对预后的影响

Prognostic impact of the metastatic lymph node number in intrahepatic cholangiocarcinoma.
PubMed 文献 · Surgery · 2022-01-20

该回顾性研究纳入87例接受肝切除且淋巴结清扫符合标准的肝内胆管癌患者,按转移淋巴结数目分为N0(45例)、N+<4(32例)和N+≥4(10例)三组。转移淋巴结数目是肿瘤学生存的预后因素(无病生存HR=1.18,总生存HR=1.21),且随着转移淋巴结数目增加,生存结局显著变差。

要点

  • 转移淋巴结数目是无病生存和总生存的预后因素。
  • N0、N+<4、N+≥4三组间无病生存和总生存均有显著差异。
  • 相邻组间(N+<4 vs N+≥4)无病生存和总生存差异显著。

核心结论

  • 在规范淋巴结清扫的前提下,转移淋巴结数目是肝内胆管癌的预后因素。

研究设计与样本

  • 回顾性研究,纳入2006年1月至2019年12月间87例接受肝切除且获取淋巴结数≥5枚并覆盖12站和8站的患者。

主要发现

  • 无病生存:N0组36.0个月(0.0-76.0) vs N+<4组8.0个月(0.0-16.9) vs N+≥4组2.0个月(0.0-5.1),P<.001。
  • 总生存:N0组69.0个月(24.5-113.5) vs N+<4组28.0个月(18.9-37.1) vs N+≥4组11.0个月(6.4-15.6),P<.001。
  • 事后分析显示相邻组间(N+<4 vs N+≥4)无病生存和总生存差异显著(P=.001)。

临床怎么用

  • 在肝内胆管癌根治术中应进行规范的淋巴结清扫以准确评估转移淋巴结数目。
  • 转移淋巴结数目可用于预后分层,数目越多预后越差。

局限性

  • 原文未述局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Lymph node metastasis in intrahepatic cholangiocarcinoma is a poor prognostic factor after radical surgery. However, unlike other biliary tract malignancies, the nodal stage of intrahepatic cholangiocarcinoma only reflects the presence of metastatic lymph nodes, not the number of metastatic lymph nodes. This study aimed to identify the prognostic impact of the metastatic lymph node number in intrahepatic cholangiocarcinoma. METHODS: The data from 87 patients with intrahepatic cholangiocarcinoma who had undergone hepatectomy with 5 or more harvested lymph nodes and covering stations 12 and 8 based on the previous criteria from January 2006 to December 2019 were retrospectively reviewed. The hazard ratio according to the increasing metastatic lymph node number was calculated with other known prognostic factors for intrahepatic cholangiocarcinoma. The patients were then divided into 3 groups according to the metastatic lymph node number (N0 [n = 45]: no metastatic lymph nodes; N+ <4 [n = 32]: 1 to 3 metastatic lymph nodes; N+ ≥4 [n = 10]: ≥4 metastatic lymph nodes). Disease-free survival and overall survival were also analyzed. RESULTS: The metastatic lymph node number was a prognostic factor of oncologic survival (disease-free survival: hazard ratio = 1.18 [1.05-1.32], P = .005; overall survival: hazard ratio = 1.21 [1.06-1.37], P = .004). Survival analysis revealed significantly poorer outcomes with an increasing metastatic lymph node number (disease-free survival: N0 vs N+ <4 vs N+ ≥4: 36.0 [0.0-76.0] vs 8.0 [0.0-16.9] vs 2.0 [0.0-5.1] months, P < .001; overall survival: N0 vs N+ <4 vs N+ ≥4: 69.0 [24.5-113.5] vs 28.0 [18.9-37.1] vs 11.0 [6.4-15.6] months, P < .001). In post hoc analysis, a significant difference was found between adjacent groups (disease-free survival and overall survival: N+ <4 vs N+ ≥4, P = .001). CONCLUSION: With proper lymph node dissection, the number of metastatic lymph nodes is a prognostic factor of intrahepatic cholangiocarcinoma.

来源:Surgery,查看原文。版权归原作者所有。

引用

  1. Kim SH, Han DH, Choi GH, et al. Prognostic impact of the metastatic lymph node number in intrahepatic cholangiocarcinoma. Surgery. 2022. PMID: 35065790. doi:10.1016/j.surg.2021.12.026

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。